Novel coronavirus infection is expected to be treated with experimental antiviral drugs.

China novel coronavirus infection, February 7, 2020 / BIOON/, China will conduct a clinical trial in China to test the effectiveness and potential of an experimental antiviral drug against new coronavirus infection Image source: mediaexpress.com The novel coronavirus (Remdesivir) can be used to help treat infectious diseases such as Ebola and SRAS Recently, researchers from China-Japan Friendship Hospital in Beijing will analyze whether the drug can effectively treat the infection of new coronavirus The test will be conducted in Wuhan The central city of the outbreak, Wuhan, has more than 17 thousand confirmed cases (previously) (Reed) Data and novel coronavirus infection in 270 patients with more than 360 deaths have been recruited Novel coronavirus, a pharmaceutical manufacturer, identified in a statement that no drug regulatory agency approved Reed's use in the world But because of the current treatment that has not been approved, the drug will be used to treat pneumonia patients with new coronavirus infection At present, the company is working with China's health officials to organize clinical trials Novel coronavirus infection in patients with pneumonia was determined Novel coronavirus is also recommended for use by China's health regulators as an antiviral drug for HIV Currently, the clinical trial of the Kaletra is being prepared 3 novel coronavirus novel coronavirus cases were discovered in California last Sunday, which has increased the total number of infected Americans to 11 cases According to WHO data, there are 146 cases of pneumonia with new coronavirus infection in at least 23 countries outside China The original source: experimental antivirus drug to be tested against new coronavirus a clinical trial to test an experimental antivirus drug's effectiveness against the new coronavirus will be produced in China as it battles a coronavirus break out there The drug Remedy - created to fight infectious diseases such as Ebola and SARS - will be tested by a medical team from Beijing-based China-Japan Friendship Hospital, a hospital spokeswoman told Bloomberg News The trial will be conducted in the central Chinese city of Wuhan, the epicenter of the outbreak that has sickened more than 17, 000 people and killed more than 360 in China Researchers will recruit up to 270 patients with mild and moderate pneumonia caused by the virus, according to Chinese news outlet The Paper, Bloomberg News reported.......